Cyclacel Pharmaceuticals (NASDAQ:CYCC) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cyclacel Pharmaceuticals (CYCC) operate in?

Cyclacel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cyclacel Pharmaceuticals Stock (NASDAQ: CYCC) stock price, news, charts, stock research, profile.

Open	$0.37
Close	-
Volume / Avg.	141.71K / 1.52M
Day Range	$0.35 - $0.37
52 Wk Range	0.32 - 4.38
Market Cap	$2.21M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	3.03%
Days to Cover	1

Recent News

Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Rocket Lab Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Cyclacel Pharmaceuticals May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

A downtrend has been apparent in Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) lately. While the stock has lost 13.8% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.37
Close	-
Volume / Avg.	141.71K / 1.52M
Day Range	$0.35 - $0.37
52 Wk Range	0.32 - 4.38
Market Cap	$2.21M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	3.03%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cyclacel Pharmaceuticals (CYCC) stock?

You can purchase shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) through any online brokerage.

View our list of the best stock brokerages

Who are Cyclacel Pharmaceuticals (CYCC) competitors?

Other companies in Cyclacel Pharmaceuticals’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Entero Therapeutics (NASDAQ:ENTO) and Quoin Pharmaceuticals (NASDAQ:QNRX).

What is the forecast, or price target, for Cyclacel Pharmaceuticals (CYCC) stock?

Cyclacel Pharmaceuticals has a consensus price target of $9.50.

What is the current price for Cyclacel Pharmaceuticals (CYCC)?

The stock price for Cyclacel Pharmaceuticals (NASDAQ: CYCC) is $0.3601 last updated December 18, 2024 at 8:24 AM EST.

Does Cyclacel Pharmaceuticals (CYCC) pay a dividend?

There are no upcoming dividends for Cyclacel Pharmaceuticals.

When is Cyclacel Pharmaceuticals (NASDAQ:CYCC) reporting earnings?

Cyclacel Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, March 18, 2025.

Is Cyclacel Pharmaceuticals (CYCC) going to split?

There is no upcoming split for Cyclacel Pharmaceuticals.

What sector and industry does Cyclacel Pharmaceuticals (CYCC) operate in?

Cyclacel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals (CYCC) Forecast